Similar articles

• How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.

  Lindstrom J. Lindstrom J. Fed Proc. 1978 Dec;37(14):2828-30. Fed Proc. 1978. PMID: 214352 No abstract available.
• Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.

  Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ. Klooster R, et al. Brain. 2012 Apr;135(Pt 4):1081-101. doi: 10.1093/brain/aws025. Epub 2012 Mar 6. Brain. 2012. PMID: 22396395
• Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.

  Cole RN, Reddel SW, Gervásio OL, Phillips WD. Cole RN, et al. Ann Neurol. 2008 Jun;63(6):782-9. doi: 10.1002/ana.21371. Ann Neurol. 2008. PMID: 18384168
• Myasthenia gravis (first of two parts).

  Drachman DB. Drachman DB. N Engl J Med. 1978 Jan 19;298(3):136-42. doi: 10.1056/NEJM197801192980305. N Engl J Med. 1978. PMID: 201840 Review. No abstract available.
• [Myasthenia, a model of a disease caused by auto-antibodies].

  Goulon M, Gajdos P, Goulon-Goëau C. Goulon M, et al. Ann Med Interne (Paris). 1987;138(6):444-61. Ann Med Interne (Paris). 1987. PMID: 2829682 Review. French. No abstract available.